Status:
COMPLETED
The Effect of Andrographis Paniculata to GLP-1, Fasting Insulin, Insulin 2-h Post OGTT, and HOMA-IR
Lead Sponsor:
Indonesia University
Conditions:
Increased Insulin
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Prevalence of type 2 diabetes have been increased, but medications had not been well, so that needed new alternatives. A new approach used in management of type 2 diabetes is incretin based therapy. I...
Detailed Description
Blood's participants will be examined fasting plasma insulin and glycated albumin (from fasting blood) and insulin measured during a standardized 2-h OGTT, DPP-4 enzyme, and GLP-1 (from standardized 2...
Eligibility Criteria
Inclusion
- Age 18 year old until 60 year old
- Normal glucose tolerance subject or prediabetes
- The kidney function (creatinine) and liver function (SGPT) in range normal
- Subject has signed agreement (informed consent)
Exclusion
- Pregnant
- Feeding baby
- Subject has comorbide or chronic disease uncontrolled
- Subject has cancer
- Subject consume medication influenced blood glucose such as steroid an suplement
- Insulin dependent diabetes
Key Trial Info
Start Date :
October 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2018
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT03455049
Start Date
October 17 2017
End Date
May 2 2018
Last Update
September 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Universitas Indonesia
Jakarta Pusat, DKI Jakarta, Indonesia, 10430